DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 190 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,032 | -79.4% | 97 | -79.0% | 0.00% | – |
| Q3 2022 | $5,000 | – | 462 | +9140.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 5 | -99.9% | 0.00% | -100.0% |
| Q3 2021 | $102,000 | +137.2% | 5,324 | +21.6% | 0.01% | +150.0% |
| Q2 2021 | $43,000 | +4200.0% | 4,379 | +6339.7% | 0.00% | – |
| Q1 2021 | $1,000 | -97.9% | 68 | -98.7% | 0.00% | -100.0% |
| Q2 2020 | $47,000 | +2250.0% | 5,390 | +702.1% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 672 | +30.2% | 0.00% | – |
| Q4 2019 | $3,000 | +200.0% | 516 | +437.5% | 0.00% | – |
| Q3 2018 | $1,000 | -87.5% | 96 | -78.1% | 0.00% | -100.0% |
| Q4 2017 | $8,000 | +14.3% | 438 | +41.7% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +40.0% | 309 | -41.8% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 531 | -35.6% | 0.00% | – |
| Q1 2017 | $5,000 | -77.3% | 824 | -85.2% | 0.00% | -100.0% |
| Q4 2016 | $22,000 | -79.4% | 5,570 | -24.0% | 0.00% | -80.0% |
| Q2 2016 | $107,000 | – | 7,331 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |